Pages that link to "Q64889492"
Jump to navigation
Jump to search
The following pages link to Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. (Q64889492):
Displaying 10 items.
- Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders (Q36699412) (← links)
- Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update (Q39463386) (← links)
- Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders (Q39478484) (← links)
- Pharmacokinetics of long acting propranolol. Implications for therapeutic use. (Q39665713) (← links)
- Clinical pharmacokinetics and endocrine disorders. Therapeutic implications (Q39693651) (← links)
- Clinical Pharmacokinetics of ??-Adrenoceptor Blocking Drugs in Thyroid Disease (Q40089881) (← links)
- Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions (Q40091895) (← links)
- Use of β-Adrenoceptor Blocking Drugs in Hyperthyroidism (Q40094041) (← links)
- Pharmacokinetic properties and bioavailability of methimazole (Q51637048) (← links)
- Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages (Q68182453) (← links)